The Addition of Sufentanil Interscalene Block in Shoulder Surgery

• Status: Completed
• Trial end date: 2012-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to compare the effects and side effects of interscale block performed with Naropin 0.1% cum sufentanil or Naropin 0.1% in shoulder surgery.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Bent Gymoese Jorgensen
• Treatments: Ropivacaine; Sufentanil

Criteria

Inclusion Criteria:

• ASA I-III

• Age 18-80

• Shoulder surgery performed under interscalene block and general anesthesia

Exclusion Criteria:

• Contraindication of interscalene block

• Severe chronic obstructive lung disease

• Non-cooperative patient

• Intolerance to opioids

• Pregnancy

• Rheumatoid arthritis and diabetes with peripheral polyneuropathy

• Chronic pain or daily opioid intake